Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print September 5, 2008
DOI: 10.2337/db08-0025

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Vestergaard, E. T.
Right arrow Articles by Jorgensen, J. O. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vestergaard, E. T.
Right arrow Articles by Jorgensen, J. O. L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of GH-signaling

Esben Thyssen Vestergaard, MD1, Lars Christian Gormsen, PhD1, Niels Jessen, PhD1, Sten Lund, Associate Professor1, Troels Krarup Hansen, PhD1, Niels Moller, Professor1, and Jens Otto Lunde Jorgensen, Professor1

1Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital, Denmark

Objective–: Ghrelin is a gut-derived peptide and an endogenous ligand for the growth hormone (GH) secretagogue receptor. Exogenous ghrelin stimulates the release of GH (potently) and adrenocorticotropic hormone (ACTH) (moderately). Ghrelin is also orexigenic, but its impact on substrate metabolism is controversial. We aimed to study direct effects of ghrelin on substrate metabolism and insulin sensitivity in human subjects.

Research Design and Methods–: Six healthy men underwent ghrelin (5 pmol/kg/min) and saline infusions in a double-blind cross-over study to study GH signaling proteins in muscle. To circumvent effects of endogenous GH and ACTH, we performed a similar study in 8 hypopituitary adults replaced with GH and hydrocortisone. The methods included a hyperinsulinemic euglycemic clamp, muscle biopsies, microdialysis, and indirect calorimetry.

Results–: In healthy subjects, ghrelin-induced GH secretion translated into acute GH receptor signaling in muscle. In the absence of GH and cortisol secretion, ghrelin acutely decreased peripheral but not hepatic insulin sensitivity together with stimulation of lipolysis. These effects occurred without detectable suppression of AMPK phosphorylation (an alleged second messenger for ghrelin) in skeletal muscle.

Conclusions–: Ghrelin infusion acutely induces lipolysis and insulin resistance independently of GH and cortisol. We hypothesize that the metabolic effects of ghrelin provide a means to partition glucose to glucose-dependent tissues during conditions of energy shortage.


Correspondence: etv{at}dadlnet.dk


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.